Category: 952138-13-5

One of the major reasons for studying chemical kinetics is to use measurements of the macroscopic properties of a system, HPLC of Formula: C8H4Cl2N2, such as the rate of change in the concentration of reactants or products with time.In a article, mentioned the application of 952138-13-5, Name is 4,7-Dichloro-1,6-naphthyridine, molecular formula is C8H4Cl2N2

SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES; LONG, Yaqiu; GENG, Meiyu; XU, Zhongliang; AI, Jing

The present invention discloses a pyrido-azacyclic compound represented by formula I, an isomer thereof, a pharmaceutically acceptable salt or a pharmaceutically acceptable solvate thereof, a preparation process thereof and a composition comprising the compound, and a use thereof as a multi-target protein kinase inhibitor in the preparation of a medicament for the treatment of diseases that are associated with protein kinase, especially c-Met, such as cancer and the like. The compound represented by formula I has potent inhibitory activity on tumor cells with overexpression of c-Met kinase, can effectively target c-Met-mediated signaling pathway, and can be used in the treatment of diseases such as cancer and the like that is caused by the overexpression of c-Met kinase.

Sometimes chemists are able to propose two or more mechanisms that are consistent with the available data. HPLC of Formula: C8H4Cl2N2, If a proposed mechanism predicts the wrong experimental rate law, however, the mechanism must be incorrect.Welcome to check out more blogs about 952138-13-5, in my other articles.

Reference£º
1,572-Naphthyridine – Wikipedia,
1,8-Naphthyridine | C8H6N566 – PubChem

952138-13-5, Chemistry is the experimental and theoretical study of materials on their properties at both the macroscopic and microscopic levels.In a patent£¬Which mentioned a new discovery about 952138-13-5

ASTRAZENECA AB; ASTRAZENECA UK LIMITED

The invention concerns naphthyridine derivatives of Formula (I): or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, G1, G2, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders or disease states associated with angiogenesis and/or vascular permeability.

952138-13-5, Interested yet? Read on for other articles about 952138-13-5!

Reference£º
1,571-Naphthyridine – Wikipedia,
1,8-Naphthyridine | C8H6N565 – PubChem